Fig. 3
From: Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease
NT-proBNP concentrations in pmol/L for each dog in the respective groups accordingly at a) baseline and b) follow-up examination, median marked as a bar. c) Significant increase in NT-proBNP concentrations from baseline (1) to follow-up (2) occurred in stage B1 patients. ROC curves with AUC for comparing NT-proBNP between dogs with stage C and d) controls AUC 0,87 (95% CI, 0.72 to 1), e) stage B1 AUC 0.85 (95% CI, 0.69 to 1), and f) stage B2. * p < 0.05, **p < 0.001